EVIDENCE-BASED IPAMORELIN INFORMATION

Ipamorelin Therapy in Jupiter, Florida

A clear, physician-led review of an investigational growth hormone secretagogue, its changing compounding status, limited human evidence, and safer clinical decision-making.

Timothy Mackey, D.O., Medical Director
Florida License OS9185 · Updated September 2026

A consultation does not guarantee a prescription. Eligible Florida patients may be seen by telemedicine when clinically appropriate.

Timothy Mackey, D.O., Medical Director of NovaGenix Health and Wellness
Timothy Mackey, D.O.Medical Director · Physician-led evaluation and monitoring
PHYSICIANIndividual evaluation
FLORIDALicense OS9185
★★★★★4.9 Google rating
A+BBB rating
MONITORINGOngoing follow-up
START WITH THE ESSENTIALS

Three things to know before deciding

01

WHAT IT IS

A synthetic peptide that activates the ghrelin receptor and can stimulate pituitary growth hormone release.

02

FDA STATUS

Ipamorelin is not FDA-approved for any indication. Its compounding status and availability have changed over time.

03

EVIDENCE

Human evidence is limited, and popular claims about fat loss, muscle, recovery, and anti-aging are not established indications.

CLINICAL CONTEXT

Understanding ipamorelin without the marketing haze

Ipamorelin is commonly described online as a selective growth hormone secretagogue. Mechanism alone, however, does not establish that a medication is safe, effective, or appropriate for a specific wellness goal.

FDA has identified concerns involving aggregation, peptide-related impurities, immunogenicity, and product characterization for compounded ipamorelin. Current availability must be confirmed rather than assumed.

Read the peptide therapy cornerstone guide →
Ipamorelin in published studies: educational summary of growth hormone pulses, selectivity, and human trial findings
Educational overview of selected published ipamorelin studies. Ipamorelin has no FDA-approved indication, and the available evidence does not establish broad claims about fat loss, muscle gain, or anti-aging outcomes. Sources: Raun et al., European Journal of Endocrinology, 1998;139:552–561. Gobburu et al., Pharmaceutical Research, 1999;16:1412–1416. Beck et al., International Journal of Colorectal Disease, 2014;29:1523–1529.
INDIVIDUALIZED DECISIONS

Who may need evaluation—and what requires caution

PHYSICIAN REVIEW

A responsible discussion covers

  • The symptom or goal prompting interest
  • Evidence-based and FDA-approved alternatives
  • Current medications, endocrine history, and labs
  • Whether any legally available option has a favorable risk-benefit profile
IMPORTANT CONTEXT

What this page does not promise

  • Guaranteed fat loss or lean-mass gain
  • Anti-aging or longevity effects
  • Faster healing or athletic recovery
  • Availability from a licensed pharmacy at any given time
HOW CARE WORKS

A four-step physician-guided process

01

Consultation

Review symptoms, goals, medical history, medications, and prior treatment.

02

Evaluation

Complete a focused exam, records review, and labs when clinically appropriate.

03

Shared decision

Compare evidence, regulatory status, alternatives, uncertainty, cost, and risk.

04

Follow-up

If treatment is appropriate, monitor response, side effects, and ongoing need.

SAFETY & MONITORING

What responsible care should address

The most important first question is not “What dose?” It is whether the substance is legally available, adequately characterized, and medically justified.

  • Ipamorelin is not FDA-approved, so safety and effectiveness have not been established for a recognized indication.
  • FDA has described potential immunogenicity and impurity concerns for compounded ipamorelin acetate.
  • Changes in IGF-1, glucose regulation, fluid retention, headache, or injection reactions are among issues a physician may consider.
  • Athletes should verify anti-doping rules; a prescription does not automatically create an exemption.

Call 911 for a medical emergency. Contact the prescribing clinician promptly for concerning or persistent symptoms.

How does ipamorelin compare to sermorelin?

They are the two peptides most often discussed together, and most comparisons online treat them as two versions of the same idea. They are not. Sermorelin acts on the GHRH receptor in the pituitary; ipamorelin acts on the ghrelin receptor. Both are compounded rather than dispensed against a current FDA approval for adult use, and both are named in the same subsection of the WADA Prohibited List.

We cover the receptor difference, the selectivity claim and what the evidence does and does not support in detail on a separate page: Sermorelin vs. ipamorelin.

How does ipamorelin compare to tesamorelin?

This is the sharper of the two comparisons, because the regulatory positions are not equivalent. Tesamorelin holds a current FDA approval, with a labeled adult dose, for reducing excess visceral abdominal fat in adults with HIV-associated lipodystrophy. Ipamorelin has never held an approval for any indication, in any population.

They also act through different receptors — tesamorelin on the GHRH receptor, ipamorelin on the ghrelin receptor — which is why the question of combining them comes up so often, and why the answer is more complicated than “two pathways, so it adds up.” The full comparison, including what the FDA has said about combination products: tesamorelin vs. ipamorelin.

EXPLORE RELATED CARE

Put this option in the right clinical context

JUPITER + FLORIDA

In-person and telemedicine care

NovaGenix serves patients at 609 N. Hepburn Ave., Suite 106, Jupiter, Florida, with telemedicine available to eligible patients throughout Florida.

COST & ACCESS

Clear next steps after evaluation

Cost and availability depend on the medically appropriate option, pharmacy or product, monitoring, and insurance status. The team explains expected costs before treatment begins.

FREQUENTLY ASKED QUESTIONS

Clear answers, without overpromising

Is ipamorelin FDA-approved?

No. Ipamorelin is not FDA-approved for any medical indication.

Can a compounding pharmacy make ipamorelin?

The federal compounding position has changed and may continue to change. Availability depends on current law, FDA policy, and what a licensed pharmacy is permitted to prepare.

Is ipamorelin proven for fat loss or muscle gain?

No. Those are common promotional claims, but robust human evidence establishing those outcomes and long-term safety is lacking.

Why does NovaGenix discuss it if availability is uncertain?

Patients encounter ipamorelin online. Clear education helps distinguish mechanism, evidence, regulatory status, and safer alternatives.

What happens during a consultation?

The physician reviews the underlying concern, history, medications, laboratories when appropriate, and evidence-based options. A consultation does not guarantee a prescription.

Start with a physician conversation

Discuss your goals, medical history, evidence-based options, and whether this therapy—or a different approach—may be appropriate.

Schedule a Consultation

Learn what you want to know about hormone therapy by scheduling a free consultation.

Contact Us Today
Location pin icon

609 N Hepburn Ave Ste 106, Jupiter, FL 33458